Gastrointestinal toxicity linked to targeted cancer therapies in the United States
"The landscape of modern oncology has evolved dramatically over the past two decades, propelled by the development and widespread use of molecularly targeted agents and cell-based immunotherapies."
2026-02-20
(Press-News.org)
“This review comprehensively examines the mechanisms, clinicopathological features, and management strategies of GI toxicity induced by TKIs, ADCs, and CAR-T therapies, emphasizing the diagnostic role of pathologists in identifying treatment-related injury patterns.”
BUFFALO, NY — February 20, 2026 — A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection.”
First author Muhammad Moseeb Ali Hashim and co-corresponding author Kamran Zahoor from the University of Missouri-Columbia examined how targeted cancer therapies, including tyrosine kinase inhibitors, antibody–drug conjugates, and CAR-T cell therapies, affect the gastrointestinal tract. The authors analyzed clinical trials, FDA drug labels, national safety databases, and pathology reports. Their findings show that these therapies can cause distinct and sometimes serious digestive injuries that are often underrecognized. Greater awareness may support earlier diagnosis, better treatment decisions, and improved patient protection.
Targeted therapies have transformed care for colorectal cancer, gastric cancer, liver cancer, and gastrointestinal stromal tumors. By focusing on specific molecular targets, these drugs offer more precise treatment than traditional chemotherapy. However, they can also harm healthy tissue in the digestive system, making gastrointestinal toxicity an important clinical concern as their use expands.
The authors outline how different drug classes produce different patterns of injury. Tyrosine kinase inhibitors may reduce blood vessel growth in the gut, leading to diarrhea, abdominal pain, bleeding, or, in rare cases, bowel perforation. Antibody–drug conjugates can damage normal intestinal lining cells, causing nausea, vomiting, mouth sores, and colitis. CAR-T cell therapy may trigger widespread immune-related inflammation that also affects the gastrointestinal tract.
These side effects can resemble infections, inflammatory bowel disease, or reduced blood flow to the intestine. Biopsy samples may show cell death, ulceration, or inflammation, which can be misinterpreted without a clear treatment history. The authors highlight the importance of close collaboration between oncologists, gastroenterologists, and pathologists to ensure accurate diagnosis.
The paper also discusses national safety monitoring systems such as the FDA Adverse Event Reporting System, which tracks reported gastrointestinal complications linked to these therapies. Combining clinical findings with pathology data and regulatory safety information can strengthen drug monitoring and enhance patient safety nationwide.
“Looking forward, progress will depend on bridging critical research gaps particularly in real-world histopathology correlation, microbiome interactions, and predictive biomarkers of toxicity while embedding digital tools for patient-reported outcomes and pharmacovigilance.”
By integrating clinical, pathological, and regulatory perspectives, this research offers a practical framework for recognizing and managing gastrointestinal toxicity associated with targeted cancer therapies. As precision oncology advances, coordinated care and informed monitoring will remain essential to keep these treatments both effective and safe.
DOI: https://doi.org/10.18632/oncoscience.643
Correspondence to: Muhammad Moseeb Ali Hashim – mhdxz@umsystem.edu; Kamran Zahoor – kzwyc@health.missouri.edu
Abstract video: https://www.youtube.com/watch?v=HEd-pnk7aUg
Keywords: cancer, gastrointestinal toxicity, tyrosine kinase inhibitors, antibody-drug conjugates, CAR-T cell therapy, targeted cancer therapy
Click here to sign up for free Altmetric alerts about this article.
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: freeing oncology from publication costs. It is free to readers and authors.
Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X
Instagram
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2026-02-20
The winning work of the Bial Award in Biomedicine 2025, selected from 58 nominations across 18 countries, will be announced at the Award Ceremony on February 24, 2026, at 6 pm, in Porto, and will be held in a hybrid format, allowing everyone to watch online.
With the amount of 350,000 Euros, this award, promoted by the Bial Foundation, seeks to recognise a work published in the broad biomedical field within the last 10 years, the results of which are considered of exceptional quality and scientific relevance.
Chaired ...
2026-02-20
The protein “neurofilament light chain” (NfL) – studied in humans in the context of neurodegenerative diseases and aging – is also detectable in the blood of numerous animals, and NfL levels increase with age in mice, cats, dogs, and horses. Experts from the DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen report these findings in the scientific journal “PLOS Biology”. In their view, this biomarker could help to assess the biological age of animals and estimate their life expectancy.
The protein NfL is an indicator of nerve damage. It is released when neurons undergo change ...
2026-02-20
Birds change altitude to survive epic journeys across deserts and seas
New study reveals how wing shape and plumage color shape migration strategies
Every year, billions of birds undertake extraordinary migrations, crossing vast deserts and open seas with no place to stop, feed, or rest. A new international study published in iScience by a consortium of researchers from Tour du Valat, CEFE/CNRS, Muséum national d'Histoire naturelle and Swiss Ornithological Institute reveals that small migratory birds adjust ...
2026-02-20
The more we rely on digital navigational tools, the more important it is that technology actually points us in the right direction.
"In challenging terrain, the margins that separate safe trails from dangerous detours are very small. If the digital track is 50 metres wrong, it can have major consequences," says Ole Edward Wattne, a researcher at the Norwegian University of Science and Technology's (NTNU) Department of Design.
How we orient ourselves
Wattne and his colleague Frode Volden have investigated how people find their way when they are in the outdoors, and whether ...
2026-02-20
CAMBRIDGE, Mass. – February 20, 2026 – Insilico Medicine (“Insilico”, 3696.HK) The convergence of generative AI, multimodal foundation models, and automated laboratory
systems is accelerating a fundamental transformation in drug discovery. Despite major technological progress, most pharmaceutical R&D remains fragmented across computational tools and manual experimentation.
To address this challenge, researchers from Insilico Medicine and Lilly published a landmark perspective in ACS Central Science describing a comprehensive framework for fully autonomous, AI-orchestrated drug discovery. The article, “From Prompt to Drug: Toward ...
2026-02-20
Munich, Germany – 20 February 2026: An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026.1 The summit is a new event organised by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), an association of the European Society of Cardiology (ESC).
Primary percutaneous coronary intervention (PCI) is a life-saving procedure used to restore blood flow as soon as possible after the onset of a heart attack (myocardial ...
2026-02-20
Tall structures like radio towers experience high wind loads that generate uplift forces at their foundations, a challenge that is increasing burden, as natural occurrences like typhoons and tornadoes become more frequent and severe. Transmission towers, telecommunication masts, and solar power installations are especially susceptible because uplift forces, rather than compressive forces, influence the foundational stability. On the other hand, the construction industry faces obstacles managing surplus excavated soil, a part of ...
2026-02-20
Origami, the traditional Japanese art of paper folding, has received considerable attention in engineering. By applying paper-folding principles, researchers have created compact structures that are flexible, lightweight, and reconfigurable across aerospace, medicine, and robotics. Moreover, origami-inspired designs have been explored at many scales, from microscopic structures such as DNA origami to large deployable systems for space applications. More recently, integrating electronics into origami structures has enabled the development of smart sensors that combine mechanical strength, ...
2026-02-20
Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematological disorders, particularly when matched donors are unavailable. While cord blood is known for its ability to tolerate genetic mismatches better than other donor sources, severe immune complications remain a major barrier to long-term survival. Now, scientists from Fujita Health University have identified a specific genetic mismatch that dramatically increases the risk of the most dangerous form of acute graft-versus-host disease (aGVHD), a complication in which donor ...
2026-02-20
Monitoring and treating heart failure (HF) is a challenging condition at any age. Several models, such as Atrial fibrillation, Hemoglobin, Elderly, Abnormal renal parameters, Diabetes mellitus (AHEAD), and BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT) compact, have been developed to predict the likelihood of a patient’s survival based on clinical factors such as arrhythmia, anemia, age, diabetes, and ejection fraction. However, previous studies have shown that these tools, which were developed for European and North American populations, consistently underestimate the risk among older East Asian patients. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Gastrointestinal toxicity linked to targeted cancer therapies in the United States
"The landscape of modern oncology has evolved dramatically over the past two decades, propelled by the development and widespread use of molecularly targeted agents and cell-based immunotherapies."
